aid_data_record_id,sector_name,title,description,staff_comments,combined_text,success,error_message,primary_class,confidence,project_type,justification,evidence
96777,HEALTH,Industrial and Commercial Bank of China contributes to EUR 500 million loan facility to Aspen Finance (Linked to Project ID#96776),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (EUR 18.5 million) was derived by dividing the total amount of funds loaned (EUR 500 million) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
Industrial and Commercial Bank of China contributes to EUR 500 million loan facility to Aspen Finance (Linked to Project ID#96776)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,Loan facility for corporate refinancing and general corporate functions without direct environmental or energy transition impact,Purpose is to refinance existing debts and sustain general corporate functions of pharmaceutical company
96795,HEALTH,Industrial and Commercial Bank of China contributes to EUR 1.15 billion revolving credit facility to Aspen Finance (Linked to Project ID#96796),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (EUR 42.5 million) was derived by dividing the total amount of funds loaned (EUR 1.15 billion) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
Industrial and Commercial Bank of China contributes to EUR 1.15 billion revolving credit facility to Aspen Finance (Linked to Project ID#96796)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,"Project involves financial services for corporate debt refinancing and general corporate functions, with no direct environmental or energy transition impact","Revolving credit facility for debt refinancing and general corporate purposes, no specific environmental or energy-related components"
96796,HEALTH,China Construction Bank contributes to EUR 1.15 billion revolving credit facility to Aspen Finance (Linked to Project ID#96795),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (EUR 42.5 million) was derived by dividing the total amount of funds loaned (EUR 1.15 billion) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
China Construction Bank contributes to EUR 1.15 billion revolving credit facility to Aspen Finance (Linked to Project ID#96795)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,Project involves financial services for corporate debt refinancing with no direct environmental or energy transition impact,Revolving credit facility for general corporate functions and debt refinancing in healthcare sector
96797,HEALTH,China Construction Bank contributes to ZAR 6 billion loan facility to Aspen Pharmacare (Linked to Project ID#96798),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (ZAR 222.2 million) was derived by dividing the total amount of funds loaned (ZAR 6 billion) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
China Construction Bank contributes to ZAR 6 billion loan facility to Aspen Pharmacare (Linked to Project ID#96798)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,"Project involves financial services for corporate debt refinancing and general corporate functions in the healthcare sector, with no direct environmental or energy transition impact","Loan facilities for debt refinancing and general corporate functions, healthcare sector focus"
96798,HEALTH,Industrial and Commercial Bank of China contributes to ZAR 6 billion loan facility to Aspen Pharmacare (Linked to Project ID#96797),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (ZAR 222.2 million) was derived by dividing the total amount of funds loaned (ZAR 6 billion) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
Industrial and Commercial Bank of China contributes to ZAR 6 billion loan facility to Aspen Pharmacare (Linked to Project ID#96797)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,"Loan facility for refinancing and general corporate functions in the healthcare sector, with no direct environmental or energy transition impact",ZAR 6 billion loan facility to Aspen Pharmacare for refinancing existing debts and sustaining general corporate functions
96799,HEALTH,Industrial and Commercial Bank of China contributes to ZAR 2 billion revolving credit facility to Aspen Pharmacare (Linked to Project ID#96800),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (ZAR 74 million) was derived by dividing the total amount of funds loaned (ZAR 2 billion) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
Industrial and Commercial Bank of China contributes to ZAR 2 billion revolving credit facility to Aspen Pharmacare (Linked to Project ID#96800)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,Project involves financial services for corporate debt refinancing and general corporate functions in the healthcare sector,"Revolving credit facilities for debt refinancing, healthcare/pharmaceutical sector focus"
96800,HEALTH,China Construction Bank contributes to ZAR 2 billion loan facility to Aspen Pharmacare (Linked to Project ID#96799),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (ZAR 74 million) was derived by dividing the total amount of funds loaned (ZAR 2 billion) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
China Construction Bank contributes to ZAR 2 billion loan facility to Aspen Pharmacare (Linked to Project ID#96799)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,"The project involves financial services for refinancing and general corporate functions in the healthcare sector, with no direct environmental or energy transition impact",Loan facilities for refinancing existing debts and sustaining general corporate functions of a pharmaceutical company
96801,HEALTH,Industrial and Commercial Bank of China contributes to AUD 350 million revolving credit facility to Aspen Asia Pacific (Linked to Project ID#96803),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (AUD 12.96 million) was derived by dividing the total amount of funds loaned (AUD 350 million) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
Industrial and Commercial Bank of China contributes to AUD 350 million revolving credit facility to Aspen Asia Pacific (Linked to Project ID#96803)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,"The project involves financial services for corporate refinancing and general corporate functions, with no direct environmental or energy transition impact","Revolving credit facility for debt refinancing and general corporate functions, healthcare sector involvement"
96803,HEALTH,China Construction Bank contributes to AUD 350 million revolving credit facility to Aspen Asia Pacific (Linked to Project ID#96801),"On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.","1. For the time being, AidData assumes equal contribution of all lenders. The value of the financing organization's loan (AUD 12.96 million) was derived by dividing the total amount of funds loaned (AUD 350 million) by the number of lenders in the syndicate (27).","# Sector
HEALTH

# Title
China Construction Bank contributes to AUD 350 million revolving credit facility to Aspen Asia Pacific (Linked to Project ID#96801)

# Description
On May 17, 2018, Aspen Pharmacare Holdings Ltd. signed six multi-currency (EUR, ZAR, AUD) loan facilities made to three subsidiary corporate entities totaling the equivalent of EUR 3.6 billion. All facilities were combined into a single facility agreement, within which all lenders were placed on equal footing. All facilities had a one-year extension option. All facilities were lent by the same international syndicate containing twenty-seven (27) entities, including the China Construction Bank's (CCB) Johannesburg branch and the Industrial and Commercial Bank of China (ICBC) Thai Bank. The purpose of all the facilities was to refinance the Aspen group's existing debts and sustain the group's general corporate functions.  Three facilities were made to Aspen Finance (Pty) Ltd. The first was a EUR 1 billion loan facility with an initial maturity date of two (2) years (CCB: #96773, ICBC: #96774). The second was a EUR 500 million loan facility with an initial maturity date of four (4) years (CCB: #96776, ICBC: #96777). The third was a EUR 1.15 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96795, ICBC: #96796).  Two facilities were made to Pharmacare Limited. The first was a ZAR 6 billion loan facility with an initial maturity date of four (4) years (CCB: #96797, ICBC: #96798). The second was a ZAR 2 billion revolving credit facility with an initial maturity date of four (4) years (CCB: #96799, ICBC: #96800).  One facility was made to Aspen Asia Pacific Pty Ltd. It was an AUD 350 million revolving credit facility with an initial maturity date of four (4) years (CCB: #96801, ICBC: #96803).  The syndicate structure was identical for all facilities. MUFG Bank and Nedbank acted as initial mandated lead arrangers and bookrunners. ABSA Bank, BofA Securities (formerly known as Bank of America Merrill Lynch), BNP Paribas, Citi Bank U.A.E., FirstRand Bank, Investec, Mizuho Bank, JPMorgan Chase Bank's London branch, Standard Chartered Bank, Standard Finance (Isle of Man), Standard Bank of South Africa, and Sumitomo Mitsui Banking Corporation (SMBC) Europe acted as mandated lead arrangers and bookrunners. Intesa Sanpaolo Bank Luxembourg, MMI Group, National Australia Bank, and Sanlam Investment Group acted as mandated lead arrangers. China Construction Bank's (CCB) Johannesburg branch, Industrial and Commercial Bank of China (ICBC) Thai Bank, and Commonwealth Bank of Australia acted as lead arrangers. Afrasia Bank, CaixaBank, Deutsche Bank Luxembourg, Bank of Ireland Group PLC, Mauritius Commercial Bank, and Westpac Banking Corporation acted as arrangers.  All facilities were guaranteed by Aspen Pharmacare Holdings Limited, Pharmacare Limited, Aspen Global Incorporated, Aspen Asia Pacific Pty Ltd, Aspen Finance (Pty) Ltd, Aspen Nutritionals Australia Pty Ltd, Aspen Pharmacare Australia Pty Ltd, Aspen Pharma Pty Ltd, and Orphan Holdings Pty Ltd.",TRUE,NA,NEUTRAL,HIGH,Financial Services,"Project involves financial services for corporate debt refinancing and general corporate functions, with no direct environmental or energy transition impact",Revolving credit facility for debt refinancing and general corporate purposes in healthcare sector
98695,BANKING AND FINANCIAL SERVICES,"ICBC contributes to a $300 million USD syndicated loan to South Africa's Investec Bank Limited for refinancing purposes (linked to projects #98650, 98651, 98652)","On March 20, 2018, ICBC contributed to a $300 million USD syndicated loan to South Africa's Investec Bank Limited. The purpose of this loan was to refinance an April 2016 $635 million USD loan (project #98650, 98651, 98652). The loan carried a maturity period of two years with a one-year extension option and an interest rate of 3.329%.   Commerzbank, ICBC, and Mizuho co-ordinated the new facility and BayernLB was the facility agent. All 12 of the banks came in at the same level as book runner and mandated lead arranger. The rest of the banks were Citi, HSBC, ING, JP Morgan, Lloyds, Mizuho, and MUFG.","1. Since no other information was found, Aiddata assumes that each financer contributed equally at 30,000,000 USD.2. Aiddata calculates the interest rate by adding the 6-month LIBOR rate (1.839%) + basis points (1.4%) = 3.239%","# Sector
BANKING AND FINANCIAL SERVICES

# Title
ICBC contributes to a $300 million USD syndicated loan to South Africa's Investec Bank Limited for refinancing purposes (linked to projects #98650, 98651, 98652)

# Description
On March 20, 2018, ICBC contributed to a $300 million USD syndicated loan to South Africa's Investec Bank Limited. The purpose of this loan was to refinance an April 2016 $635 million USD loan (project #98650, 98651, 98652). The loan carried a maturity period of two years with a one-year extension option and an interest rate of 3.329%.   Commerzbank, ICBC, and Mizuho co-ordinated the new facility and BayernLB was the facility agent. All 12 of the banks came in at the same level as book runner and mandated lead arranger. The rest of the banks were Citi, HSBC, ING, JP Morgan, Lloyds, Mizuho, and MUFG.",TRUE,NA,NEUTRAL,HIGH,Financial Services,Project involves financial services with no direct environmental impact or energy transition implications,"Syndicated loan for refinancing purposes, banking sector involvement"
